EPISODE · Oct 6, 2021 · 50 MIN
The OJC 51: Prostate Cancer Screening, ASCO IO Guidelines and Infigratinib
from The Oncology Podcast · host Oncology News Australia
Send us Fan MailThe Oncology Journal Club - Delivering Oncology News DifferentlyThe Oncology Podcast, brought to you by Oncology News Australia, is proud to present Episode 51 in our series The Oncology Journal Club.Welcome to this week's episode of The OJC. Join Eva Segelov, Craig Underhill and Hans Prenen as they review an eclectic mix of papers covering prostate cancer screening, ASCO guidelines for immunotherapy for locally advanced esophageal carcinoma, infigratinib in advanced or metastatic cholangiocarcinoma with FGFR2 fusions or rearrangements, Quick Bites, Zoom Fatigue and much, much more!We hope you enjoy the Amazing Article of the Week, the Practice Tip of the Week and have a few laughs too.Full bios and the list of all papers discussed are available on our website.For the latest oncology news visit www.oncologynews.com.au and for regular oncology updates for healthcare professionals, subscribe for free to get the weekly The Oncology Newsletter.The Oncology Podcast - An Australian Oncology Perspective
Embed this episode
What this episode covers
Send us Fan Mail The Oncology Journal Club - Delivering Oncology News Differently The Oncology Podcast, brought to you by Oncology News Australia, is proud to present Episode 51 in our series The Oncology Journal Club. Welcome to this week's episode of The OJC. Join Eva Segelov, Craig Underhill and Hans Prenen as they review an eclectic mix of papers covering prostate cancer screening, ASCO guidelines for immunotherapy for locally advanced esophageal carcinoma, infigratinib in advanced or m...
NOW PLAYING
The OJC 51: Prostate Cancer Screening, ASCO IO Guidelines and Infigratinib
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.